FBLN7 and Its Role in Vascular Remodeling in Hypertension
Author Information
Author(s): Yao Guoqing, Zheng Xuehui, Hu Yang, Zhao Yuan, Kong Binghui, Ti Yun, Bu Pei li
Primary Institution: State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, 250012, China
Hypothesis
Does FBLN7 influence vascular remodeling and its underlying mechanisms?
Conclusion
FBLN7 promotes the transition of vascular smooth muscle cells from a contractile to a synthetic phenotype, aggravating vascular remodeling.
Supporting Evidence
- FBLN7 expression was significantly elevated in hypertensive patients compared to healthy controls.
- FBLN7 knockout mice showed reduced vascular remodeling in response to Ang II.
- Overexpression of FBLN7 exacerbated vascular remodeling in mice.
- FBLN7 interacts with syndecan-4, affecting its signaling and dimer formation.
Takeaway
FBLN7 is a protein that helps blood vessel cells change their shape, which can make blood vessels stiffer and lead to high blood pressure problems.
Methodology
The study used FBLN7 knockout and overexpression mice, along with various assays including RNA sequencing and western blot to analyze vascular remodeling.
Limitations
The study did not use VSMC-specific FBLN7 knockout or transgenic mice, limiting direct evidence of FBLN7's function in VSMCs.
Participant Demographics
35 hypertensive patients and 47 age-matched healthy individuals.
Statistical Information
P-Value
1.86E-04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website